Home
Scholarly Works
Comparison of First-line Pazopanib and Sunitinib...
Preprint

Comparison of First-line Pazopanib and Sunitinib in Metastatic Renal Cell Carcinoma: Experiences of the Urologic Cancer Centre for Research and Innovation

Authors

Wong ECL; Tajzler C; Vasisth G; Zhu A; Chow M; Lovatt C; Hotte S; Kapoor A

Publication date

December 6, 2019

DOI

10.21203/rs.2.18147/v1

Preprint server

Research Square
View published work (Non-McMaster Users)

Contact the Experts team